See your results below for :
Brixadi 1ML of 128MG/0.36ML
:
Syringe - 1
Brixadi Coupons & Prices
What is Brixadi ?
Brixadi (buprenorphine) is a once-weekly or once-monthly extended-release injectable medication approved for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a transmucosal buprenorphine-containing product. It functions primarily as a partial agonist at opioid receptors, helping to prevent withdrawal symptoms and reduce opioid cravings. Brixadi is intended to be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
Brixadi
Consumer Forms
Consumer Routes
Therapeutic Classes
- Nausea
- Headache
- Dizziness
- Constipation
- Vomiting
- Sweating
- Sleep disturbances
- Risk of opioid addiction, abuse, and misuse, which can lead to overdose and death
- Serious, life-threatening, or fatal respiratory depression may occur
- Accidental ingestion can result in a fatal overdose of buprenorphine
- Neonatal opioid withdrawal syndrome may occur in newborn infants of mothers who are treated with buprenorphine during pregnancy
- Concomitant use with benzodiazepines or other CNS depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death